facebook

Edelweiss PMS Focused Mid/Smallcap

Scheme Rating

IME Scheme Rating

The Scheme does not meet our selection criteria at this time

Not a recommended fund: This is not a recommended fund, primarily because the AMC does not meet our selection criteria. We believe that there are better fund houses to invest in, within the Indian mutual fund universe.

IME Strategy Rating

Small & Mid Cap Focused: The portfolio focuses on the companies in small & midcap space which have high earnings growth, with emphasis on good earnings quality available at a reasonable valuation. The key tenet of the fund is ‘Share prices are slaves of earnings growth.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on Edelweiss PMS Focused Mid/Smallcap

Type: Small Cap | GARP | AUM (66 cr) | Inc Date (3 Aug 2015)

Edelweiss Focused Small Cap- Investment Strategy

Edelweiss FSP focuses on companies in small-mid cap space which have demonstrated growth or market leadership. Quality of earnings and balance sheet risk are given higher importance than the growth of earnings. Investment strategy is divided into three buckets – Strategic, Tactical, and Options – based on the nature of the business and investment horizon.

Trailing Performance

1yr 3yr 5yr Since Inception
Edelweiss PMS Focused Mid/Smallcap 25.3 16.9 18.5 10.2
S&P BSE 500 TRI 39.5 19.5 19 13
Alpha over Broad Mkt BM -14.2 -2.6 -0.5 -2.8
Nifty Smallcap 250 67.7 29.7 25.2
Alpha over Category BM -42.4 -12.8 -6.7

Performance as of: 28-Feb-23 | Inception Date: 03-Aug-15

Fund Managers

Sahil Shah | 3-star rated FM

Fund Manager | 17 yrs Experience | 9 yrs at current firm

Past Experience: Edelweiss Research (Analyst), Anagram Capital (Analyst)

Sahil Shah has over 10 years of equity research experience, with a focus on the auto, power and small-mid caps sectors.

Fee Structure

Fee StructureFee
Fixed Fee Structure2.5
Variable Fee Structures1.5% fixed + 20% above no hurdle
Exit Fees1yr(2%), 2yr(1%), 3yr(0.75%)

AMC

AMC: Edelweiss PMS (click link for detailed AMC review)

Not a recommended AMC: Edelweiss has not succeeded in scaling up its investment capabilities on the equity fund management side, to the same level it has built up its other business units. We would wait for their AUM to scale and investment team to stabilise & mature prior to recommending investments.

Edelweiss PMS does not meet our criteria for PMS AMC Selection at this time. Understand our AMC rating criteria at AMC Rating Criteria or contact us via the LiveChat to learn more.

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.